Brief: Vyne Therapeutics And Yarrow Bioscience Announce Merger Agreement
17/12/2025 13:26
Dec 17 (Reuters) - Vyne Therapeutics Inc VYNE.O: VYNE THERAPEUTICS AND YARROW BIOSCIENCE ANNOUNCE MERGER AGREEMENT VYNE THERAPEUTICS INC - COMBINED COMPANY TO TRADE UNDER TICKER 'YARW' VYNE THERAPEUTICS INC - PRE-CLOSING FINANCINGS OF $200 MILLION TO FUND OPERATIONS INTO 2028 VYNE THERAPEUTICS INC - COMBINED COMPANY TO BE NAMED YARROW BIOSCIENCE, LED BY REBECCA FREY VYNE THERAPEUTICS - TO DECLARE CASH DIVIDEND TO PRE-MERGER VYNE STOCKHOLDERS OF $14.5 MILLION-$16.5 MILLION Source text: ID:nGNX3wt10V Further company coverage: VYNE.O ((Reuters.Briefs@thomsonreuters.com;))